Stay updated on Efgartigimod SC in Bullous Pemphigoid: Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.15.2, replacing the previous version v2.15.0. Additionally, the phrasing regarding the last update has been clarified.
    Difference
    0.1%
    Check dated 2025-05-01T06:25:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the termination of certain studies and the introduction of new study timelines and safety assessments related to Efgartigimod PH20 SC for Bullous Pemphigoid. Key dates have been revised, and several previously listed assessments have been removed.
    Difference
    25%
    Check dated 2025-04-24T01:29:37.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the safety and efficacy of efgartigimod PH20 SC for bullous pemphigoid, and the addition of a new revision number.
    Difference
    11%
    Check dated 2025-04-16T20:41:07.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T16:03:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-02T00:25:26.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T23:18:25.000Z thumbnail image

Stay in the know with updates to Efgartigimod SC in Bullous Pemphigoid: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.